125 / 182
FIVE
| 121
Integrated Report 2016
ANNUAL FINANCIAL STATEMENTS
(continued)
SIX
THREE
ONE
FOUR
TWO
Geographical segments are reported as the Group operates in Southern Africa, Rest of Africa and India.
The Group’s reportable segments in Southern Africa are as follows:
•
Over the Counter (OTC) – focuses primarily on brands sold predominantly in the pharmacy market, where the pharmacist plays a role in the
product choice;
•
Consumer – competes in the Fast Moving Consumer Goods (FMCG) space;
•
Prescription – market products prescribed by medical practitioners; and
•
Hospital – supplier of hospital and critical care products, including intravenous solutions, blood collection products and renal dialysis systems.
The financial information of the Group’s reportable segments is reported to key management for purposes of making decisions about
allocating resources to the segment and assessing its performance. Segment figures for management purposes equal the disclosures made in
the segment report and agree with the IFRS amounts in the annual financial statements.
No operating segments have been aggregated to form the above reportable operating segments.
2016
R’000
2015
R’000
STATEMENT OF COMPREHENSIVE INCOME
Turnover
Continuing operations
Southern Africa
5 388 857
5 022 770
OTC
1 668 438
1 454 224
Consumer
662 981
628 991
Prescription
1 830 669
1 812 735
Hospital
1 226 769
1 126 820
Rest of Africa
178 594
147 400
Research and development services in India
15 099
11 565
5 582 550
5 181 735
Less:
Intercompany sales
(36 940)
(22 834)
5 545 610
5 158 901
Discontinued operations
India
258 936
257 672
Rest of Africa (Ghana)
144 956
111 796
403 892
369 468
The South African Government represents more than 10% of the Group’s turnover, arising in the following
segments:
OTC
67 700
57 492
Consumer
431
2 608
Prescription
284 570
252 474
Hospital
412 972
374 491
765 673
687 065
TRADING AND OPERATING PROFIT
Continuing operations
Southern Africa
607 043
520 894
OTC
310 022
260 717
Consumer
90 476
79 301
Prescription
171 453
148 099
Hospital
35 092
32 777
Rest of Africa
(3 522)
(4 261)
Research and development services in India
2 173
1 393
Trading profit
605 694
518 026
Less
: Non-trading expenses
(52 449)
(18 960)
Operating profit
553 245
499 066
ANNEXURE A – SEGMENT REPORT